SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-043366
Filing Date
2023-08-18
Accepted
2023-08-18 09:00:11
Documents
73
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q impl-20230630.htm   iXBRL 10-Q 2774652
2 EX-10.1 impl-ex10_1.htm EX-10.1 103662
3 PDF COURTESY COPY impl-ex10_1.pdf EX-10.1 482177
4 EX-31.1 impl-ex31_1.htm EX-31.1 20852
5 EX-31.2 impl-ex31_2.htm EX-31.2 20886
6 EX-32.1 impl-ex32_1.htm EX-32.1 9772
7 EX-32.2 impl-ex32_2.htm EX-32.2 10139
  Complete submission text file 0000950170-23-043366.txt   9982834

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT impl-20230630_pre.xml EX-101.PRE 426583
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT impl-20230630_lab.xml EX-101.LAB 583643
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT impl-20230630.xsd EX-101.SCH 73664
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT impl-20230630_def.xml EX-101.DEF 241878
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT impl-20230630_cal.xml EX-101.CAL 48938
67 EXTRACTED XBRL INSTANCE DOCUMENT impl-20230630_htm.xml XML 1440845
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Filer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: 10-Q | Act: 34 | File No.: 001-40353 | Film No.: 231183855
SIC: 2834 Pharmaceutical Preparations